Welltower Shorts Stay Quiet as Analysts Crowd the Bull Side

Welltower enters its October 26 Q3 earnings report with short sellers holding an unusually small and stable position, while analyst conviction keeps building toward the top of the REIT universe.

Short interest is running at 2.6% of the free float, a level that has barely moved in a month. The shares outstanding on loan have ticked up fractionally over the past week, roughly 100,000 shares added, but the month-on-month direction is flat to slightly lower. The borrow market reflects the same indifference: cost to borrow is 0.38%, down 15% from a month ago, and availability is near 4,900% of short interest, meaning there are roughly 49 shares available to lend for every one already borrowed. Short sellers face no pressure and are in no hurry.

The analyst picture is the more active story. Wells Fargo raised its target to $268 on October 19, keeping Overweight, the latest in a string of constructive moves. The consensus target now stands at $260.55, against a closing price of $237.40, a gap of roughly 10%. Welltower's analyst recommendation factor ranks in the 99th percentile of its universe. Not all moves were positive: Barclays cut its target from $259 to $246 on October 13, holding Equal-Weight, citing valuation. That dissent is worth noting. The stock has gained 2% over the past month, and the put/call ratio of 1.08 is only modestly above its 20-day average of 1.05, a z-score of 0.70, so options traders are not pricing in dramatic downside. The debate is less about direction and more about whether the current multiple, a P/E near 75 and EV/EBITDA close to 30, is justified by the pace of senior housing occupancy recovery.

Welltower rose 1.2% over the past week. Most of its closest healthcare REIT peers moved in the opposite direction over the same period: VTR fell 1.3% on the day alone, OHI dropped 2.4%, and SBRA lost 2.7%. That relative resilience matters as context for the print: the stock is carrying a performance premium into results. The Q2 report in July produced a one-day decline of nearly 3% and a five-day drop of around 7%, so the market's post-earnings behavior has not always matched the bullish pre-print consensus. Capital Research added more than 11 million shares in the quarter to September 30, becoming the second-largest institutional holder at 9.4% of shares. That is a meaningful new buyer at scale.

The October 26 print will test whether Welltower's senior housing operating metrics can support a valuation that the most positive analysts on the Street are only just beginning to catch up with.